Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03083405
Other study ID # WMU1/2017
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 20, 2017
Est. completion date December 2024

Study information

Verified date May 2024
Source Wroclaw Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Sleep apnea is a common and serious health problem in the Polish population. According to epidemiological data problem concerns about 7% of the adult population. The most common sleep disorder is obstructive sleep apnea (OSA). The consequence of episodes of airway obstruction and sleep fragmentation is an inefficient sleep, pathological daytime sleepiness, falling asleep involuntarily, awakening with feelings of shortness of breath or throttling. The direct consequences of sleep apnea are hypoxia, increased heart rate and increased blood pressure. Frequent complications of OSA are hypertension, stroke, cardiac arrhythmia, coronary artery disease and pulmonary hypertension. An additional problem in patients with sleep apnea is an increased incidence of bruxism. Bruxism is a common problem; reports of prevalence range from 8-31% in the general population. The most common symptoms of bruxism include: hypersensitive teeth, tooth wear, damage to dental restorations (e.g. crowns and fillings), damage to periodontal and oral mucosa, masticatory muscle pain and headaches. The etiology of bruxism is multifactorial and not fully understood. It can be caused by biologic, psychologic and exogenous factors. Arousals during the apnea episodes are considered to be a major cause of sleep bruxism in OSA patients. The relationship between OSA and sleep bruxism is still not clearly defined. Further research is needed to help explain the relationship between these two phenomena, which will enable further therapy in patients with coexisting OSA and sleep bruxism (SB).


Description:

1. Introduction Sleep apnea is a common and serious health problem in the Polish population. According to epidemiological data problem concerns about 7% of the adult population. The most common sleep disorder is obstructive sleep apnea (OBS). The essences of OBS are episodes of airway obstruction repeated many times during sleep. As a result the oxygen level in blood decreases. The result of increased muscle tension of upper respiratory tract and throat vibrations is a very loud snoring restoring breath. Episodes of apnea with arousals cause sleep fragmentation, shortage of deep sleep and rapid eye movement (REM). Such episodes occur repeatedly, several, or even dozens of times per hour of sleep. The consequence of episodes of airway obstruction and sleep fragmentation is an inefficient, lack of rest sleep, pathological daytime sleepiness, falling asleep involuntarily, awakening with feelings of shortness of breath or throttling. Fragmentation of sleep and repeated episodes of hypoxia result in deterioration of quality of life, chronic fatigue and an increased risk of communication accidents. The direct consequences of sleep apnea are hypoxia, awakening, increased heart rate and increased blood pressure. Frequent complications of obstructive sleep apnea (OSA) are hypertension, stroke, cardiac arrhythmia, coronary artery disease, pulmonary hypertension and heart failure. If left untreated, OSA contributes to the development of vascular endothelial dysfunction and increases the risk of premature death, especially in men under age of 50. An additional problem in patients with sleep apnea is an increased incidence of bruxism. Bruxism is a common problem; reports of prevalence range from 8-31% in the general population. The most common symptoms of bruxism include: hypersensitive teeth, tooth wear, damage to dental restorations (e.g. crowns and fillings), damage to periodontal and oral mucosa, masticatory muscle pain and headaches. Symptoms of bruxism may go unnoticed for a long time, which implies that patients often don't know about their condition. There are two different types of bruxism: Sleep Bruxism (SB) and Awake Bruxism (AB). Type SB consists of involuntary, episodic and rhythmic activity of masticatory muscles (Rhythmic Masticatory Muscle Activity / RMMA). The etiology of bruxism is multifactorial and not fully understood.It can be caused by biologic, psychologic and exogenous factors. Arousals during the apnea episodes are considered to be a major cause of sleep bruxism in OSA patients. The relationship between obstructive sleep apnea and sleep bruxism is still not clearly defined. Further research is needed to help explain the relationship between these two phenomena, which will enable further therapy in patients with coexisting OSA and SB. 2. Aim The aim of the study is evaluation of the quality of sleep, endothelial function, cardiovascular risk, thyroid function, a function of masticatory muscles, psycho-emotional status, genetic predispositions and drug effectiveness in patients with bruxism. 3. Methods The project will take place in the Sleep Laboratory at the Department of Internal Medicine, Occupational Diseases and Hypertension Medical University in Wroclaw. About 100 patients referred to the Department of Internal Medicine, Occupational Diseases and Hypertension and Clinical Oncology for suspected sleep apnea and bruxism will be included. Patients from the Clinic of Prosthodontics operating at the Department of Prosthodontics, Medical University in Wroclaw and other dental institutions diagnosed using Diagnostic Criteria for Temporomandibular Disorders (DC / TMD) and Criteria of American Academy of Sleep Medicine International Classification of Sleep Disorders ICSD-3 evaluating bruxism will undergo polysomnography (PSG) with video recording. Polysomnograms will be evaluated in a 30-second contributions, according to standard sleep criteria. PSG results will contain data on the latency of sleep, total sleep time (TST), sleep efficiency (%) and an evaluation of phases N1, N2, N3 and REM. Pathological respiratory events will be evaluated in accordance with the standards of the American Academy of Sleep. Apnea is defined as the absence of airflow through the respiratory tract by more than 10 seconds. The shallowness of breathing is defined as a decrease in respiratory amplitude by more than 30% for more than 10 seconds, with subsequent desaturation of more than 3% or subsequent awakening. Then, to evaluate the function of vascular endothelium in patients expansion of the brachial artery using ultrasonography Aloka Prosound Alpha 6, using the guidelines of the international working group studying reactivity of the brachial artery will be explored. Ultrasound of the heart, Electrocardiography Holter and Ambulatory blood pressure monitoring (ABPM) will be performed in each patient. In addition, researchers will execute surveys: Epworth Scale, Athens Scale, STOP-Bang Scale, Berlin questionnaire, the severity level of fatigue / tiredness scale, a questionnaire assessing quality of life, the scale of perceived stress - questionnaire PSS 10 and questionnaires Oral Behavior Checklist (OBC) and Pittsburgh Sleep Quality index (PSQI). Headache episodes will be assessed using Headache Impact Test - 6 (HIT-6) and HUNT questionnaires. Each patient will be performed laboratory blood tests to determine levels of FT3, FT4 and TSH in order to evaluate the relationship between RMMA and thyroid disease and genetical tests. At the same time the relationship between bruxism, psycho-emotional state and sleep quality will be evaluated through questionnaires PSS10, OBC and PSQI. Masticatory muscle activity during the study will be assessed on the basis of the record coming from electromyography electrodes placed on the beard and symmetrically around the masseter muscle attachments. The results will then be analyzed for the incidence RMMA directly related to episodes of bruxism and their relation to episodes of sleep apnea, changes in blood pressure and heart rate to determine the prevalence of cause-effect relationships.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - diagnosed sleep bruxism - full dentition - single tooth loss - age between 18 and 70 Exclusion Criteria: - age under 18 - age over 70 - terminal general diseases - severe mental disorders - edentulism - taking drugs that could falsify polysomnography - confirmed alcoholism - drug addiction

Study Design


Intervention

Drug:
Opipramol
The study group will get a drug to decrease bruxism activity. Group will be evaluated using polysomnography included rhythmic masticatory muscle activity registration before and after intervention.

Locations

Country Name City State
Poland Wroclaw Medical University Wroclaw

Sponsors (1)

Lead Sponsor Collaborator
Wroclaw Medical University

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relationship between bruxism and quality of sleep assessed by polysomnography. Polysomnograms will be evaluated in a 30-second contributions, according to standard sleep criteria. PSG results will contain data on the latency of sleep, total sleep time (TST), sleep efficiency (%) and an evaluation of phases N1, N2, N3 and REM. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and quality of sleep assessed by Epworth scale. Each participant will fill in Epworth scale. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and quality of sleep assessed by Athens scale. Each participant will fill in Athens scale. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and quality of sleep assessed by STOP-bang questionnaire. Each participant will fill in STOP-bang questionnaire. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and quality of sleep assessed by Pittsburgh Sleep Quality Index. Each participant will fill in Pittsburgh Sleep Quality Index. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and sleep apnea assessed by polysomnography and genetical tests. Each participant will fill undergo polysomnography and genetical blood tests. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and sleep apnea assessed by Berlin questionaire. Each participant will fill in Berlin questionaire. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and cardiovascular risk assessed by ABPM. Cardiovascular risk will be assessed in each participant using ABPM. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and cardiovascular risk assessed by ECG Holter. Cardiovascular risk will be assessed in each participant using ECG Holter. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and cardiovascular risk assessed by heart ultrasonography. Cardiovascular risk will be assessed in each participant using heart ultrasonography. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and the function of vascular endothelium assessed by expansion of the brachial artery using ultrasonography. Expansion of the brachial artery will be evaluated using ultrasonography Aloka Prosound Alpha 6. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and thyroid function assessed by clinical tests of blood. Blood test determining levels of FT3, FT4, TSH and Anti-TPO will be conducted for each participant to evaluate the function of thyroid. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and masticatory muscle activity assessed by electromyography. Masticatory muscle activity during the study will be assessed on the basis of the record coming from EMG electrodes placed on the beard and symmetrically around the masseter muscle attachments. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism, quality of life and mental status assessed by the scale of perceived stress - questionnaire PSS 10. Each participant will fill in the scale of perceived stress - questionnaire PSS 10. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism, quality of life and mental status assessed by the questionnaire assessing quality of life. Each participant will fill in a questionnaire assessing quality of life. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism quality of life and mental status assessed by the severity level of fatigue scale. Each participant will fill in severity level of fatigue scale. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism quality of life and mental status assessed by the severity level of tiredness scale. Each participant will fill in severity level of tiredness scale. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and mental status assessed by Beck Depression Inventory Each participant will fill in Beck Depression Inventory. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and temporomandibular disorders (TMD). Each participant will fill in TMD pain screener, Oral Behavior Checklist. All of the participants will also undergo diagnostics in accordance to DC/TMD. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and headaches assessed by Headache Impact Test - 6 (HIT-6). Each participant will fill in HIT-6 questionnaire. 01.03.2017 - 01.03.2018
Secondary Relationship between bruxism and headaches assessed by HUNT questionnaire. Each participant will fill in HUNT questionnaire. 01.03.2017 - 01.03.2018
Secondary Effect of treatment with opipramol on bruxism episodes. Opipramol treatment will be implemented in patients with bruxism. 01.03.2017 - 01.03.2018
Secondary Is bruxism genetically determined? Each patient will undergo genetical blood test. 01.03.2017 - 01.03.2018
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A